Training courses & Webinars:
Vigilance

“It was brill for an overview! Questions were answered by the speaker and the atmosphere made me feel really comfortable and allowed me to ask the questions in a confident way.”

Shelley Browning, Regulatory and PV Manager, Weleda

“Very informative and interesting webinar. Well explained by the speaker, who was very knowledgeable and experienced.”

Aimee Wright, R & D Manager (Agricultural), EVANS VANODINE INTERNATIONAL PLC

“It was a very thorough explanation on the licensing aspects in PhV. It helped me understand the process better and to improve myself in the pharmacovigilance and regulatory fields.”

Vlad Vorotneac, Pharmacovigilance Agreement Associate, Teva Pharmaceuticals Romania

“Both presenters were so good and delivered a very clear message. After changing company I now have all I need to back up my experience with. Thank you both!”

Said Alfredsson, PV Agreement Manager, Ferring IPC

“The course gave me a basis for some challenges in relation to obligations and negotiations related to the pharmacovigilance operation in the face of the growing number of partnerships that my company has been establishing. Very useful explanation! Very thoughtful speakers. They answered all questions and brought practical examples.”

Gabriela Diniz, Pharmacovigilance Manager , Eurofarma

“Very In depth training - all though a lot of theoretical stuff. Overall good for me.”

Augustina Kanu, Pharmacovigilance, Chiesi Ltd

“[The speaker was] very professional and knowledgeable.”

Priyanka Parasher, Global Pharmacovigilance and Product Information officer, Nelsons

“Graeme was knowledgeable on all the material. [Overall] very good and informative.”

Nicholas Gurreri, Safety scientist, GSK

“Very informative. Good content.”

Anna-Faye Halls, Pharmacovigilance Coordinator, GW Pharmaceuticals

“I am pleased with the webinar. I feel like I learned a lot. For now I will try to get some real experience with writing PSUR and adverse events and then I would like to proceed with the advanced webinar on veterinary pharmacovigilance.”

Natascha van Heugten-Cappelle, QPPV, Aesculaap BV